Trond Warloe
- Dermatology top 0.5%
- Cancer and Skin Lesions 4
-
- Photodynamic Therapy Research Studies 30
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics 18
- Epidemiology top 2%
- Nonmelanoma Skin Cancer Studies 15
- Ophthalmology top 2%
-
- Esophageal Cancer Research and Treatment 8
- Esophageal and GI Pathology 6
-
- Porphyrin and Phthalocyanine Chemistry 7
-
- Oral Health Pathology and Treatment 4
Trond Warloe
47 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Dermatology 703
- Pulmonary and Respiratory Medicine 2.1k
- Biomedical Engineering 1.3k
- Epidemiology 992
- Ophthalmology 218
Countries citing papers authored by Trond Warloe
This map shows the geographic impact of Trond Warloe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trond Warloe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trond Warloe more than expected).
Fields of papers citing papers by Trond Warloe
This network shows the impact of papers produced by Trond Warloe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trond Warloe. The network helps show where Trond Warloe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Trond Warloe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 4 | |
| 4 | 2022 | 9 | |
| 5 | 2015 | 16 | |
| 6 | 2014 | 3 | |
| 7 | 2013 | 36 | |
| 8 | 2011 | 18 | |
| 9 | 2009 | 84 | |
| 10 | 2008 | 40 | |
| 11 | 2007 | 22 | |
| 12 | 2003 | 136 | |
| 13 | 2001 | 169 | |
| 14 | 2001 | 155 | |
| 15 | 1998 | 15 | |
| 16 | The reciprocal translocation t(9;16)(q22;p13) is a primary chromosome abnormality in basal cell carcinomas. | 1997 | 19 |
| 17 | 5-Aminolevulinic acid-based photodynamic therapybreakdown → | 1997 | 827 |
| 18 | 1995 | 148 | |
| 19 | Multiple glove powder granulomas masquerading as peritoneal carcinomatosis. | 1994 | 17 |
| 20 | Is it possible to reduce the incidence of drug related gastrointestinal bleeding | 1986 | 2 |
About Trond Warloe
Trond Warloe is a scholar working on Pulmonary and Respiratory Medicine, Dermatology, Periodontics, Epidemiology and Ophthalmology, having authored 48 papers that have together received 3.0k indexed citations. Recurring topics across this work include Photodynamic Therapy Research Studies (30 papers), Nanoplatforms for cancer theranostics (18 papers), Nonmelanoma Skin Cancer Studies (15 papers), Esophageal Cancer Research and Treatment (8 papers), Porphyrin and Phthalocyanine Chemistry (7 papers), Esophageal and GI Pathology (6 papers), Oral Health Pathology and Treatment (4 papers) and Cancer and Skin Lesions (4 papers). The work is most often cited by research in Dermatology (703 citations), Pulmonary and Respiratory Medicine (2.1k citations), Biomedical Engineering (1.3k citations), Epidemiology (992 citations) and Ophthalmology (218 citations). Trond Warloe has collaborated with scholars based in Norway, China and Sweden. Frequent co-authors include Qian Peng, Johan Moan, Karl-Erik Giercksky, Kristian Berg, Jahn M. Nesland, Magne Kongshaug, Jahn M. Nesland, A. Soler, Karl‐Erik Giercksky and Even Angell‐Petersen. Their work appears in journals such as British Journal of Dermatology, Journal of the European Academy of Dermatology and Venereology, Acta Oncologica, Cancer and Photodiagnosis and Photodynamic Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.